Schizophrenia risk gene CAV1 is both pro-psychotic and required for atypical antipsychotic drug actions in vivo

John Allen, P. N. Yadav, V. Setola, M. Farrell, B. L. Roth

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Caveolin-1 (Cav-1) is a scaffolding protein important for regulating receptor signaling cascades by partitioning signaling molecules into membrane microdomains. Disruption of the CAV1 gene has recently been identified as a rare structural variant associated with schizophrenia. Although Cav-1 knockout (KO) mice displayed no baseline behavioral disruptions, Cav-1 KO mice, similar to schizophrenic individuals, exhibited increased sensitivity to the psychotomimetic N-methyl-D-aspartate receptor antagonist phencyclidine (PCP). Thus, PCP disruption of prepulse inhibition (PPI) and PCP-induced mouse locomotor activity were both enhanced by genetic deletion of Cav-1. Interestingly, genetic deletion of Cav-1 rendered the atypical antipsychotics clozapine and olanzapine and the 5-HT 2A -selective antagonist M100907 ineffective at normalizing PCP-induced disruption of PPI. We also discovered that genetic deletion of Cav-1 attenuated 5-HT 2A -induced c-Fos and egr-1 expression in mouse frontal cortex and also reduced 5-HT 2A -mediated Ca 2 mobilization in primary cortical neuronal cultures. The behavioral effects of the 5-HT 2A agonist (2,5-dimethoxy-4-iodoamphetamine) including head twitch responses and disruption of PPI were also attenuated by genetic deletion of Cav-1, indicating that Cav-1 is required for both inverse agonist (that is, atypical antipsychotic drug) and agonist actions at 5-HT 2A receptors. This study demonstrates that disruption of the CAV1 genea rare structural variant associated with schizophreniais not only pro-psychotic but also attenuates atypical antipsychotic drug actions.

Original languageEnglish (US)
Article numbere33
JournalTranslational Psychiatry
Volume1
DOIs
StatePublished - 2011
Externally publishedYes

Fingerprint

Caveolin 1
Antipsychotic Agents
Schizophrenia
Genes
Serotonin
olanzapine
Knockout Mice
Membrane Microdomains
Receptor, Serotonin, 5-HT2A
Phencyclidine
Serotonin Receptor Agonists
Clozapine
Frontal Lobe
Locomotion
N-Methyl-D-Aspartate Receptors
Head

Keywords

  • 5-HT2A
  • antipsychotic
  • caveolin
  • clozapine
  • schizophrenia

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry
  • Cellular and Molecular Neuroscience

Cite this

Schizophrenia risk gene CAV1 is both pro-psychotic and required for atypical antipsychotic drug actions in vivo. / Allen, John; Yadav, P. N.; Setola, V.; Farrell, M.; Roth, B. L.

In: Translational Psychiatry, Vol. 1, e33, 2011.

Research output: Contribution to journalArticle

@article{1b7f453ab35742679cf75e32b456b229,
title = "Schizophrenia risk gene CAV1 is both pro-psychotic and required for atypical antipsychotic drug actions in vivo",
abstract = "Caveolin-1 (Cav-1) is a scaffolding protein important for regulating receptor signaling cascades by partitioning signaling molecules into membrane microdomains. Disruption of the CAV1 gene has recently been identified as a rare structural variant associated with schizophrenia. Although Cav-1 knockout (KO) mice displayed no baseline behavioral disruptions, Cav-1 KO mice, similar to schizophrenic individuals, exhibited increased sensitivity to the psychotomimetic N-methyl-D-aspartate receptor antagonist phencyclidine (PCP). Thus, PCP disruption of prepulse inhibition (PPI) and PCP-induced mouse locomotor activity were both enhanced by genetic deletion of Cav-1. Interestingly, genetic deletion of Cav-1 rendered the atypical antipsychotics clozapine and olanzapine and the 5-HT 2A -selective antagonist M100907 ineffective at normalizing PCP-induced disruption of PPI. We also discovered that genetic deletion of Cav-1 attenuated 5-HT 2A -induced c-Fos and egr-1 expression in mouse frontal cortex and also reduced 5-HT 2A -mediated Ca 2 mobilization in primary cortical neuronal cultures. The behavioral effects of the 5-HT 2A agonist (2,5-dimethoxy-4-iodoamphetamine) including head twitch responses and disruption of PPI were also attenuated by genetic deletion of Cav-1, indicating that Cav-1 is required for both inverse agonist (that is, atypical antipsychotic drug) and agonist actions at 5-HT 2A receptors. This study demonstrates that disruption of the CAV1 genea rare structural variant associated with schizophreniais not only pro-psychotic but also attenuates atypical antipsychotic drug actions.",
keywords = "5-HT2A, antipsychotic, caveolin, clozapine, schizophrenia",
author = "John Allen and Yadav, {P. N.} and V. Setola and M. Farrell and Roth, {B. L.}",
year = "2011",
doi = "10.1038/tp.2011.35",
language = "English (US)",
volume = "1",
journal = "Translational Psychiatry",
issn = "2158-3188",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Schizophrenia risk gene CAV1 is both pro-psychotic and required for atypical antipsychotic drug actions in vivo

AU - Allen, John

AU - Yadav, P. N.

AU - Setola, V.

AU - Farrell, M.

AU - Roth, B. L.

PY - 2011

Y1 - 2011

N2 - Caveolin-1 (Cav-1) is a scaffolding protein important for regulating receptor signaling cascades by partitioning signaling molecules into membrane microdomains. Disruption of the CAV1 gene has recently been identified as a rare structural variant associated with schizophrenia. Although Cav-1 knockout (KO) mice displayed no baseline behavioral disruptions, Cav-1 KO mice, similar to schizophrenic individuals, exhibited increased sensitivity to the psychotomimetic N-methyl-D-aspartate receptor antagonist phencyclidine (PCP). Thus, PCP disruption of prepulse inhibition (PPI) and PCP-induced mouse locomotor activity were both enhanced by genetic deletion of Cav-1. Interestingly, genetic deletion of Cav-1 rendered the atypical antipsychotics clozapine and olanzapine and the 5-HT 2A -selective antagonist M100907 ineffective at normalizing PCP-induced disruption of PPI. We also discovered that genetic deletion of Cav-1 attenuated 5-HT 2A -induced c-Fos and egr-1 expression in mouse frontal cortex and also reduced 5-HT 2A -mediated Ca 2 mobilization in primary cortical neuronal cultures. The behavioral effects of the 5-HT 2A agonist (2,5-dimethoxy-4-iodoamphetamine) including head twitch responses and disruption of PPI were also attenuated by genetic deletion of Cav-1, indicating that Cav-1 is required for both inverse agonist (that is, atypical antipsychotic drug) and agonist actions at 5-HT 2A receptors. This study demonstrates that disruption of the CAV1 genea rare structural variant associated with schizophreniais not only pro-psychotic but also attenuates atypical antipsychotic drug actions.

AB - Caveolin-1 (Cav-1) is a scaffolding protein important for regulating receptor signaling cascades by partitioning signaling molecules into membrane microdomains. Disruption of the CAV1 gene has recently been identified as a rare structural variant associated with schizophrenia. Although Cav-1 knockout (KO) mice displayed no baseline behavioral disruptions, Cav-1 KO mice, similar to schizophrenic individuals, exhibited increased sensitivity to the psychotomimetic N-methyl-D-aspartate receptor antagonist phencyclidine (PCP). Thus, PCP disruption of prepulse inhibition (PPI) and PCP-induced mouse locomotor activity were both enhanced by genetic deletion of Cav-1. Interestingly, genetic deletion of Cav-1 rendered the atypical antipsychotics clozapine and olanzapine and the 5-HT 2A -selective antagonist M100907 ineffective at normalizing PCP-induced disruption of PPI. We also discovered that genetic deletion of Cav-1 attenuated 5-HT 2A -induced c-Fos and egr-1 expression in mouse frontal cortex and also reduced 5-HT 2A -mediated Ca 2 mobilization in primary cortical neuronal cultures. The behavioral effects of the 5-HT 2A agonist (2,5-dimethoxy-4-iodoamphetamine) including head twitch responses and disruption of PPI were also attenuated by genetic deletion of Cav-1, indicating that Cav-1 is required for both inverse agonist (that is, atypical antipsychotic drug) and agonist actions at 5-HT 2A receptors. This study demonstrates that disruption of the CAV1 genea rare structural variant associated with schizophreniais not only pro-psychotic but also attenuates atypical antipsychotic drug actions.

KW - 5-HT2A

KW - antipsychotic

KW - caveolin

KW - clozapine

KW - schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=80052324943&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052324943&partnerID=8YFLogxK

U2 - 10.1038/tp.2011.35

DO - 10.1038/tp.2011.35

M3 - Article

C2 - 22832607

AN - SCOPUS:80052324943

VL - 1

JO - Translational Psychiatry

JF - Translational Psychiatry

SN - 2158-3188

M1 - e33

ER -